Authors, including highly cited cancer researcher, blame “clerical error” for image mixup in paper

The Journal of Experimental Medicine has issued a correction for a 2011 paper by Michael Karin, a prominent cancer researcher at the University of California, San Diego, after learning about a “clerical error” in one of the figures. According to the notice for the article, “Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied … Continue reading Authors, including highly cited cancer researcher, blame “clerical error” for image mixup in paper

Retraction four appears for management professor Ulrich Lichtenthaler

Ulrich Lichtenthaler, a management professor at the University of Mannheim who has retracted three papers for statistical irregularities, has another retraction for his CV, this one in the Strategic Management Journal. There’s no notice yet; all that appears for the January 2012 paper is this:

Pharmacology journal expresses concern over “similar, but updated” review

The British Journal of Clinical Pharmacology has issued an “expression of concern” for a 2003 review article, based on a previous lecture, with close echoes to a paper that had appeared in one of The Lancet titles. Here’s the notice for the article, by Peter Winstanley, dean of the Warwick Medical School in the United … Continue reading Pharmacology journal expresses concern over “similar, but updated” review

Cardiff University looking into allegations of misconduct by group headed by its dean of medicine

Last December, we reported on a Journal of Immunology paper that was retracted after a Cardiff University investigation found the senior author had inappropriately manipulated images.  The inquiry found that there had been “no intention to mislead and subsequent repeats of the original experiments have shown that the paper’s conclusions remain sound,” the university told … Continue reading Cardiff University looking into allegations of misconduct by group headed by its dean of medicine

Transparency in action: EMBO Journal detects manipulated images, then has them corrected before publishing

As Retraction Watch readers know, we’re big fans of transparency. Today, for example, The Scientist published an opinion piece we wrote calling for a Transparency Index for journals. So perhaps it’s no surprise that we’re also big fans of open peer review, in which all of a papers’ reviews are made available to readers once … Continue reading Transparency in action: EMBO Journal detects manipulated images, then has them corrected before publishing

Plagiarism topples paper co-authored by top tamoxifen scientist

Expert Opinion on Pharmacotherapy has retracted a 2011 paper for plagiarism by two authors, one of whom, V. Craig Jordan, is a leading researcher on the class of drugs known as selective estrogen receptor modulators, or SERMs, and is credited with discovering the anti-tumor properties of the breast cancer drug tamoxifen. Jordan, who is scientific … Continue reading Plagiarism topples paper co-authored by top tamoxifen scientist

When is it acceptable to use some of the same data in separate papers?

Duplication — sometimes referred to “self-plagiarism,” with a lack of precision — is a frequent cause of retractions. Usually, it’s of text that authors have used elsewhere. But what about data? In our new LabTimes column, we describe a hypothetical situation:

Canada’s Memorial U says “substantial data misrepresentation” described by retraction notice was unintentional

Yesterday, we reported on a retraction in the Journal of Neuroscience for “substantial data misrepresentation.” When we posted, the authors’ institution, Memorial University in Newfoundland, Canada, had not been able to respond to our questions yet, because of the long Canada Day weekend. This morning, they sent us the following statement, which describes the errors … Continue reading Canada’s Memorial U says “substantial data misrepresentation” described by retraction notice was unintentional

Controversial paper on life-extending buckyballs corrected after blog readers note problems

Back in April, a group of French and Tunisian researchers published a paper in Biomaterials which came to the astonishing conclusion that buckyballs (carbon tetrachloride) coated in olive oil could dramatically extend the lives of lab rodents. That news was picked up by Derek Lowe’s In the Pipeline blog, on which he expressed some bemusement … Continue reading Controversial paper on life-extending buckyballs corrected after blog readers note problems

JPET peeves: Paper withdrawn after drug company won’t disclose chemical structure

A group of researchers at the drug company ChemoCentryx is withdrawing a 2012 paper in the Journal of Pharmacology and Experimental Therapeutics over failure to appropriately identify the molecule they describe in the article. The withdrawal notice tells the story: